TY  - JOUR
AU  - Liras, Antonio
AU  - García-Tenchard, Rebecca
PY  - 2013
DO  - 10.1586/17474086.2013.834798
SN  - 1747-4086,  1747-4094 (ESSN)
UR  - https://hdl.handle.net/20.500.14352/34703
T2  - Expert review of hematology
AB  - With the eradication of infection by HIV and hepatitis C virus that were common just a few years ago, the most concerning adverse effect resulting from the use of both recombinant and plasma-derived products is the appearance of antibodies...
LA  - eng
M2  - 489
PB  - Informa Healthcare
KW  - Hemophilia
KW  - Treatment
KW  - Plasma
TI  - Treatment for hemophilia: recombinant versus plasma-derived coagulationfactors – controversy and debateforever? An ethical medical challenge?
TY  - journal article
VL  - 6
ER  -